Treatment of NAFLD and NASH
US9616039B2 · kind B2 · utility
25Cited by
16References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2016 |
| Grant date | Apr 11, 2017 |
| Priority date | — |
| Expiry date | Jun 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.